CCRT for Esophageal Cancer.

• Status: Completed
• Trial end date: 2015-11-01

Summary

This study aimed at assessing the efficiency and safety of concurrent chemoradiotherapy (CCRT) using paclitaxel (PTX) plus oxaliplatin (OHP) in unresectable locally advanced esophageal cancer patients.

• Phase: Phase 2

Details

• Lead Sponsor: Hangzhou Cancer Hospital
• Treatments: Albumin-Bound Paclitaxel; Oxaliplatin; Paclitaxel